← Eichor
Study identifier: NCT06754657 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery

Condition: Arthropathy Shoulder · Pain, Acute · Anesthesia  ·  Sponsor: Pontificia Universidad Catolica de Chile

PhasePhase 4
Planned participants150
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery. The participants will: * Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.

This description comes directly from the study's public registry record.

Talk to the study team

Fernando R Altermatt, MD  ·  56955049115  ·  falterma@uc.cl

Victor Contreras, MSN  ·  56223543414  ·  vecontre@uc.cl

Always discuss trial participation with your own doctor first.

Locations (1)

Red de Salud UC ChristusSantiago, ChileRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06754657